Orlando D. Navarro-Ulloa, Instituto de Cardiología del Caribe, Cartagena, Colombia
Luis G. Salgado-Montiel, Departamento de Medicina Interna, Universidad de Cartagena, Cartagena, Colombia
Valeria Granados-Duque, Departamento de Medicina Interna, Universidad de Cartagena, Cartagena, Colombia
Yesus Ramírez-Carrascal, Facultad de Medicina, Universidad de Cartagena, Cartagena, Colombia
Amaury Ariza-García, Departamento de Medicina Interna, Universidad de Cartagena; Departamento de Nefrología, Hospital Universitario del Caribe, ESE. Cartagena, Colombia
Cardiorenal syndrome results from a close relationship between heart and kidney. Five phenotypes of this complex interaction have been defined. Type 1 cardiorenal syndrome is characterized in that a picture of acute heart failure generates acute kidney injury. This syndrome is usually accompanied by volume overload that clinically manifests with signs of congestion. Within the treatment of congestion there are some pharmacological treatment options: loop diuretics, thiazide diuretics, carbonic anhydrase inhibitors and sodium-glucose cotransporter inhibitors. When these treatment fails, the use of renal support therapies is proposed, with the aim of achieving decongestion. The following review intends to analyze the indications, advantages and limitations of each therapy.
Keywords: Cardiorenal syndrome. Acute heart failure. Acute kidney injury. Fluid overload. Diuretics. Ultrafiltration.
